| Payton Cerda, PA | |
|
2510 W Horizon Ridge Pkwy Ste 130, Henderson, NV 89052-1600 | |
| (702) 263-7800 | |
| Not Available |
| Full Name | Payton Cerda |
|---|---|
| Gender | Male |
| Speciality | Physician Assistant |
| Experience | 6 Years |
| Location | 2510 W Horizon Ridge Pkwy Ste 130, Henderson, Nevada |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1740747542 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | PA2098 (Nevada) | Secondary |
| 363AM0700X | Physician Assistant - Medical | PA2098 (Nevada) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Digestive Associates Llp | 7810067741 | 18 |
News Archive
The UK is all set to launch its run into the future as the undisputed leader in the field of personalized and effective radiation therapy. The proposal is undergirded by a whopping £56 million, which will be used to set up and fund advanced radiation therapy research by a new collaborative setup, Cancer Research UK RadNet, over five years. This is the largest sum ever invested by this organization into radiotherapy research.
Derma Sciences, Inc., a medical device and pharmaceutical company focused on advanced wound care, announces that the U.S. Patent and Trademark Office has issued patent No. 7,714,183 related to the Company's MEDIHONEY Calcium Alginate Dressing.
Surgeons from UC Davis Medical Center have demonstrated that artificial muscles can restore the ability of patients with facial paralysis to blink, a development that could benefit the thousands of people each year who no longer are able to close their eyelids due to combat-related injuries, stroke, nerve injury or facial surgery.
HIV/AIDS is a major security threat to the military, Ugandan Gen. Katumba Wamala, commander of the country's Land Forces, said recently at the 2008 HIV/AIDS Implementers' Meeting in Kampala, Uganda, the New Vision/AllAfrica.com reports.
AqueSys, Inc., a medical device company that develops, manufactures and distributes proprietary implants for glaucoma, today announced that it has secured $35 million in Series C financing. The round was led by Longitude Capital and Rho Ventures, with participation from existing investors Accuitive Medical Ventures, The Carlyle Group and SV Life Sciences.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Payton Cerda, PA 1350 W Horizon Ridge Pkwy Apt 722, Henderson, NV 89012-4434 Ph: (818) 405-7521 | Payton Cerda, PA 2510 W Horizon Ridge Pkwy Ste 130, Henderson, NV 89052-1600 Ph: (702) 263-7800 |
News Archive
The UK is all set to launch its run into the future as the undisputed leader in the field of personalized and effective radiation therapy. The proposal is undergirded by a whopping £56 million, which will be used to set up and fund advanced radiation therapy research by a new collaborative setup, Cancer Research UK RadNet, over five years. This is the largest sum ever invested by this organization into radiotherapy research.
Derma Sciences, Inc., a medical device and pharmaceutical company focused on advanced wound care, announces that the U.S. Patent and Trademark Office has issued patent No. 7,714,183 related to the Company's MEDIHONEY Calcium Alginate Dressing.
Surgeons from UC Davis Medical Center have demonstrated that artificial muscles can restore the ability of patients with facial paralysis to blink, a development that could benefit the thousands of people each year who no longer are able to close their eyelids due to combat-related injuries, stroke, nerve injury or facial surgery.
HIV/AIDS is a major security threat to the military, Ugandan Gen. Katumba Wamala, commander of the country's Land Forces, said recently at the 2008 HIV/AIDS Implementers' Meeting in Kampala, Uganda, the New Vision/AllAfrica.com reports.
AqueSys, Inc., a medical device company that develops, manufactures and distributes proprietary implants for glaucoma, today announced that it has secured $35 million in Series C financing. The round was led by Longitude Capital and Rho Ventures, with participation from existing investors Accuitive Medical Ventures, The Carlyle Group and SV Life Sciences.
› Verified 3 days ago